What the FDA labels say about taking them together
Atropine and mexiletine
Atropine's FDA label of May 18, 2026 names mexiletine in its drug interactions section; the mexiletine label PlainMeds reads does not name atropine. The atropine label: “DRUG INTERACTIONS Mexiletine: Decreases rate of mexiletine absorption.”
Check it at the source: the atropine FDA label on DailyMed (effective May 18, 2026, Hospira, Inc.); the mexiletine FDA label on DailyMed (effective May 14, 2026, Macleods Pharmaceuticals Limited).
What does the atropine label say about mexiletine?
Atropine label, drug interactionsDRUG INTERACTIONS Mexiletine: Decreases rate of mexiletine absorption.
Source: FDA drug label (Atropine Sulfate), Hospira, Inc., effective May 18, 2026 (SPL set ad8916e7-206e-409e-2582-30d072845dd4), via openFDA; the full label on DailyMed
What does the mexiletine label say about atropine?
Mexiletine's label (effective May 14, 2026) does not name atropine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Mexiletine Hydrochloride), Macleods Pharmaceuticals Limited, effective May 14, 2026 (SPL set a61a07f6-0b48-4dcd-ad42-5d90f6e69ab1), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Atropine | Mexiletine | |
|---|---|---|
| Labeled for | n/a | n/a |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $7.74 per mL 1% eye drops | $0.222 per capsule 150 mg capsule |
| Shortage now | In shortage | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once